United States Patent 5,319,097: Scope, Claims, and US Patent Landscape
U.S. Patent 5,319,097 claims a narrowly defined crystalline monohydrate physical form of a specific sulphonamide API (plus an IR/XRD identity set), and a spray-drying process to make that specific physical form. The scope is driven by physical-form limitations (monohydrate, crystallinity, IR peak set, powder XRD peak set, melting point band) and process limitations (spray drying; optionally aqueous acetone solution).
What does the patent claim in substance?
Core subject matter
The patent centers on:
-
A specific API identity (fixed chemical structure)
N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methylbenzenesulphonamide
The claims do not cover salts, polymorphs of different hydration states, or other crystal families.
-
A specific physical form
- Monohydrate
- Crystalline
- Defined by a specific infra-red (IR) spectral signature (given as “0.5% in KBr” with sharp peaks)
- Defined by a specific powder X-ray diffraction (XRPD/XRD) peak pattern at specified 2θ angles
- In some claims, also defined by melting point ranges and by being “substantially free” of other forms
-
A specific manufacturing route to that physical form
- Spray drying a solution of the API
- Optional solvent system: aqueous acetone solution
- The process claims are tied to the product’s identity features (IR and melting point ranges in claim 5)
What exactly are the claim elements and how tightly do they constrain scope?
Claim 1: Physical form identity by IR + XRD (no melting point required)
Claim 1 claims:
- A physical form of the named API
- It is a monohydrate
- It is crystalline
- It has an IR spectrum (0.5% in KBr) with sharp peaks at:
3560, 1690, 1660, 1540, 1440, 1165, 880, 858 cm-1
- It has an X-ray powder diffraction pattern with peaks at:
2θ = 10.0°, 11.2°, 14.6°, 19.8°, 23.0°
Scope effect: Any accused product must match all of these limitations (monohydrate + crystalline + IR peak set + XRD peak set). The claim is “analytically anchored,” meaning infringement hinges on whether the product’s measured spectral patterns fit the claimed peak sets.
Claim 2: Same physical form + melting point band
Claim 2 depends on claim 1 and adds:
- Same monohydrate crystalline physical form with the same IR and XRD peak sets
- Melting point range: 145°C to 155°C
Scope effect: Claim 2 tightens eligibility by adding a thermal property band.
Claim 3: “Substantially free” of other physical forms
Claim 3 depends on claim 1 and adds:
- The monohydrate crystalline form is substantially free of any other physical forms
Scope effect: This limits the claim to products where other polymorphs/hydrate forms are not present above a threshold of “substantially free.” Enforcement typically turns into analytical quantification in disputes.
Claim 4: “Substantially free” of other crystalline forms
Claim 4 depends on claim 1 and adds:
- The physical form is substantially free of other crystalline forms
Scope effect: Similar to claim 3 but phrased specifically for “other crystalline forms,” not necessarily other physical forms that are non-crystalline.
Claim 5: Process claim tied to IR peaks (different IR set) + melting point band
Claim 5 is the first process claim and has a different analytical descriptor:
- A process for preparing a physical form of the same named API
- The target physical form must have:
- IR spectrum (0.5% in KBr) with sharp peaks at:
1690, 1530, 1490, 1420, 1155, 1060, 862, 550 cm-1
- Melting point between 115°C and 140°C
- Process comprises:
spray drying a solution of the API (same named compound)
Scope effect: The process claim is limited to spray drying and to a product definition via IR and a narrower melting point band. This matters because the IR peak sets in claim 5 do not match the claim 1/2 IR set exactly, and the melting point band in claim 5 (115–140°C) differs from claim 2 (145–155°C). In infringement or validity analysis, this tension becomes central: the process claim is not simply “make the monohydrate of claim 1,” it is “make a physical form defined by claim 5’s IR and lower melting range.”
Claim 6: Same process but specifies solvent
Claim 6 depends on claim 5 and adds:
- An aqueous acetone solution is used
Scope effect: Limits process scope to spray drying from aqueous acetone (or at least using that solvent system).
Claim 7: Solution claim
Claim 7 recites:
- A solution of the named API in aqueous acetone
Scope effect: This is a composition claim for the feed solution (not the spray-dried solid itself). It can capture upstream activities that provide the solvent system even before spray drying.
How do the analytical parameters define enforceable boundaries?
IR peak sets differ across claims
- Claim 1 IR peaks (0.5% in KBr):
3560, 1690, 1660, 1540, 1440, 1165, 880, 858 cm-1
- Claim 5 IR peaks (0.5% in KBr):
1690, 1530, 1490, 1420, 1155, 1060, 862, 550 cm-1
Implication for scope: The patent’s claimed “physical form” identity is claim-dependent. A product matching claim 1’s IR set is not automatically matching claim 5’s IR set.
XRD peak pattern is fixed in claims 1/2
- XRD 2θ peaks (claims 1/2):
10.0°, 11.2°, 14.6°, 19.8°, 23.0°
Implication for scope: XRPD gives a relatively objective fingerprint, but enforcement can still depend on instrumentation, background subtraction, and peak matching tolerances.
What is the likely scope as it would be read by a court?
Best reading: “physical-form patents” with analytical claim boundaries
These are classic physical-form claims where:
- The API chemical identity is fixed.
- The physical form is defined by hydration state + crystallinity + analytical signatures.
- The process claims are tied to producing a physical form meeting an analytical/thermal definition.
Most likely carve-outs by design
Because the claims are analytical and hydration-specific, the patent is not written to cover:
- Anhydrous crystal forms
- Other hydrates (e.g., dihydrate, sesquihydrate)
- Amorphous forms
- Other crystalline polymorphs not matching the specific XRD and IR sets
US patent landscape: what this patent blocks (and what it likely does not)
1) “Direct product infringement” pathway
This patent blocks activities that manufacture or sell a solid matching:
- the monohydrate crystalline form, and
- the claim 1/2 IR and XRD fingerprints, and
- where relevant, “substantially free” of other forms.
Key observation: the claim set is narrow enough that a competitor can design around by changing:
- hydrate state (anhydrous or other hydrate), or
- polymorph/crystal habit, and
- spray-drying conditions that lead to a different solid form.
2) “Process infringement” pathway
This patent also reaches spray-drying production if:
- the process uses spray drying from the relevant solution, and
- the resulting physical form meets claim 5’s IR and melting band.
Key observation: claim 5’s product-definition (IR peaks and melting range 115–140°C) differs from claim 1/2. A process that yields a different solid form may fall outside claim 5 even if it produces a monohydrate elsewhere in the process stream.
3) Upstream supply-chain reach via solution claim (claim 7)
A party supplying aqueous acetone solutions of the API may be exposed under claim 7, depending on how “solution” is interpreted (concentration, purity, and whether it is isolated feed for spray drying versus incidental mixing).
4) Licensing leverage is tied to analytical re-identification
Because these are physical-form claims:
- claim value is maximized when the manufacturer relies on a controlled polymorph/hydrate control strategy,
- and when competitors cannot reliably produce the desired commercial solid without generating the claimed identity.
Claim-by-claim scope map (what must match for infringement)
| Claim |
What is claimed |
Must be true about the product |
Identity anchors |
| 1 |
Monohydrate crystalline solid of named API |
Monohydrate + crystalline + matches IR and XRD peak sets |
IR: 3560, 1690, 1660, 1540, 1440, 1165, 880, 858 cm-1; XRD: 10.0°, 11.2°, 14.6°, 19.8°, 23.0° |
| 2 |
Same as claim 1 |
All claim 1 conditions + melting point 145–155°C |
Adds melting point band |
| 3 |
Same as claim 1 |
Claim 1 conditions + substantially free of other physical forms |
Qualitative impurity threshold (“substantially free”) |
| 4 |
Same as claim 1 |
Claim 1 conditions + substantially free of other crystalline forms |
Qualitative impurity threshold (“substantially free”) |
| 5 |
Spray-drying process to prepare a physical form |
Resulting solid must match claim 5 IR peaks and melting 115–140°C |
IR: 1690, 1530, 1490, 1420, 1155, 1060, 862, 550 cm-1; mp 115–140°C |
| 6 |
Spray-drying process with solvent limitation |
As claim 5 plus aqueous acetone solution |
Solvent system: aqueous acetone |
| 7 |
Aqueous acetone solution of named API |
Existence of solution in aqueous acetone |
Composition/solvent limitation |
What matters in claim scope: the “monohydrate” and “fingerprint” combination
The patent’s scope is defined by a two-layer test:
- Material layer: the API is in a monohydrate crystalline state.
- Fingerprint layer: the form must show specific IR peaks and (claims 1/2) a specific XRD peak pattern.
This combination creates a high bar for competitors: even if a product is the same chemical compound, changes in hydration and crystal form can move it outside the claimed set.
Key Takeaways
- U.S. 5,319,097 is a physical-form patent covering a monohydrate crystalline solid of the named sulphonamide, identified by specific IR and XRD peak sets.
- Claims 1-4 are tightly limited to the claim 1/2 identity set, including “substantially free” qualifiers.
- Claims 5-6 cover a spray-drying process that produces a physical form defined by a different IR peak set and a lower melting point band (115–140°C) than the melting band in claims 1-2.
- Claim 7 reaches an aqueous acetone feed solution, adding an upstream compliance hook tied to solvent selection.
FAQs
1) Does the patent cover the anhydrous form?
No. The claims explicitly require a monohydrate physical form (claims 1-4).
2) Are the IR peak requirements the same across all claims?
No. Claim 1 uses one IR peak list; claim 5 uses a different IR peak list, and the melting point bands also differ.
3) What analytical methods define the protected form most strongly?
For claims 1-2: IR (KBr, 0.5%) and powder XRD (2θ peaks), with claim 2 additionally requiring a melting range.
4) Does the process claim automatically cover making the claim 1 solid?
Not necessarily. Claim 5’s product definition uses its own IR peak list and melting range (115–140°C), which does not match claim 2’s melting range (145–155°C).
5) Which claim most directly impacts manufacturing steps?
Claims 5-6, because they require spray drying and (in claim 6) aqueous acetone.
References
[1] U.S. Patent 5,319,097.
